Dynamic Technology Lab Private Ltd purchased a new stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,490 shares of the company's stock, valued at approximately $545,000.
Several other hedge funds have also modified their holdings of the company. Rakuten Securities Inc. acquired a new position in Ryan Specialty during the 4th quarter valued at approximately $27,000. Principal Securities Inc. lifted its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after acquiring an additional 415 shares during the period. Mizuho Bank Ltd. acquired a new stake in Ryan Specialty during the 4th quarter worth about $49,000. Headlands Technologies LLC grew its stake in Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company's stock valued at $51,000 after purchasing an additional 767 shares during the last quarter. Finally, Quarry LP increased its holdings in shares of Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Ryan Specialty
In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of the company's stock in a transaction on Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the sale, the director now owns 45,409 shares of the company's stock, valued at $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 241,360 shares of company stock valued at $16,006,428. 11.10% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of brokerages recently commented on RYAN. UBS Group upped their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. TD Cowen began coverage on shares of Ryan Specialty in a research note on Thursday. They issued a "buy" rating and a $89.00 price objective on the stock. Royal Bank of Canada decreased their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. Wells Fargo & Company lowered their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday. Finally, Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $75.67.
Check Out Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Price Performance
RYAN stock traded up $0.81 during mid-day trading on Friday, reaching $72.76. 929,680 shares of the company's stock were exchanged, compared to its average volume of 941,983. The company has a market cap of $19.06 billion, a price-to-earnings ratio of 105.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $77.16. The stock's 50 day moving average is $70.05 and its 200 day moving average is $68.88. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.66%. The ex-dividend date was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is 69.57%.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.